Advertisement

Topics

Mersana Presents New Data on Investigational Cancer Antibody Drug Conjugate at American Association of Cancer Research Annual Meeting

07:00 EST 2 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Poster Presentations Detail Advances in Company’s Lead Oncology ADC Compound, XMT-1522 Mersana Therapeutics, Inc., a biotechnology company focused on discovering and developing a pipeline of antibody drug conjugates...

Other Sources for this Article

Media Contact
Paul Kidwell PR
Paul Kidwell, 617-680-1088
paulkidwell@comcast.net
or
Investors Contact
Stern Investor Relations, Inc.
Christina Tartaglia, 212-362-1200
Christina@sternir.com

NEXT ARTICLE

More From BioPortfolio on "Mersana Presents New Data on Investigational Cancer Antibody Drug Conjugate at American Association of Cancer Research Annual Meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...